cagrilintide semaglutide combination cagrisema phase 3 2025 Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, 3a study Novo Nordisk: Obesity drug CagriSema

Talk with your health care team about other things you can do to lower your chances of developing diabetes complications

The relationship between semaglutide and menstruation is not fully understood and requires more research, but the current evidence suggests that while it can influence menstrual cycles, the impact varies individually, often correlating with weight changes and insulin sensitivity alterations.

Autoimmune disorders related cardiomyopathy Notably systemic lupus erythematosus (SLE), rheumatoid arthritis, and dermatomyositis are implicated in secondary CMs through chronic inflammation and immune-driven metabolic dysregulation

Editor-in-Chief, Carlat Report Olanzapine for anorexia nervosa

O.JakobsenT